Related Experiment Videos

MicroRNAs in cholangiociliopathies

Tatyana Masyuk1, Anatoliy Masyuk, Nicholas LaRusso

  • 1Miles and Shirley Fiterman Center for Digestive Diseases, Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.

Cell Cycle (Georgetown, Tex.)
|April 4, 2009
PubMed

Insights

MicroRNAs (miRNAs) are implicated in polycystic liver diseases, known as cholangiociliopathies. Deregulation of miRNA pathways, like miR-15a influencing cell cycle regulators, is a novel mechanism in hepatic cyst development.

Area of Science:

  • Hepatology
  • Molecular Biology
  • Genetics

Background:

  • Polycystic liver diseases, termed cholangiociliopathies, are characterized by hepatic cyst formation.
  • The underlying molecular mechanisms of cholangiociliopathies are not fully understood.
  • MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression and are increasingly recognized for their roles in disease.

Purpose of the Study:

  • To review current findings on the role of miRNAs in polycystic liver diseases (cholangiociliopathies).
  • To highlight the emerging mechanism of miRNA pathway deregulation in the development of these conditions.
  • To discuss the potential of miRNAs in regulating key cellular processes involved in hepatic cystogenesis.

Main Methods:

  • Literature review of experimental studies and recent data.
  • Analysis of experimental evidence implicating specific miRNAs (e.g., miR-15a) in hepatic cyst growth.
  • Discussion of cellular processes affected by miRNAs in the context of cholangiogenesis.

Main Results:

  • Deregulation of miRNA pathways is a novel mechanism contributing to cholangiociliopathies.
  • Specific miRNAs, such as miR-15a, influence hepatic cyst growth by modulating cell cycle regulators like Cdc25A.
  • Abnormalities in cell cycle regulation, proliferation, signaling pathways, and fluid secretion are linked to hepatic cystogenesis.

Conclusions:

  • miRNAs play a significant role in the pathogenesis of cholangiociliopathies.
  • Targeting miRNA pathways presents a potential therapeutic strategy for polycystic liver diseases.
  • Further research into miRNA regulation of cellular processes is crucial for understanding and treating these conditions.

Related Concept Videos

Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
Chronic Pancreatitis I: Introduction01:25

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...